StemoniX's Convertible Note Round

StemoniX raised a round of funding on January 12, 2016.

StemoniX provides products and services for drug discovery and development. It structures human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic …

Articles about StemoniX's Convertible Note Round: